市場調查報告書

神經補綴的全球市場 - 類型,技術,用途,各地區 - 成長,趨勢,及預測(2018年∼2023年)

Neuroprosthetics Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 661183
出版日期 內容資訊 英文 120 Pages
商品交期: 2-3個工作天內
價格
神經補綴的全球市場 - 類型,技術,用途,各地區 - 成長,趨勢,及預測(2018年∼2023年) Neuroprosthetics Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年02月01日內容資訊: 英文 120 Pages
簡介

全球神經補綴市場在2018年到2023年間,預測將以約12.4%的年複合成長率增長。神經補綴是一系列裝置,可以替代因受傷或疾病而受損的運動,感覺或認知方式的功能。

本報告提供神經補綴的全球市場調查,提供市場概要,類型·技術·用途,各地區的市場趨勢,市場規模的變化與預測,市場促進·阻礙因素以及市場機會分析,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 簡介

  • 市場定義

第2章 調查方法

第3章 摘要整理

第4章 主要影響要素

第5章 市場概要

  • 目前市場方案
  • 波特的五力分析
    • 供應商談判力
    • 消費者談判力
    • 新加入廠商的威脅
    • 替代產品與服務的威脅
    • 產業內的競爭

第6章 成長要素,阻礙因素,機會,課題分析

  • 市場成長要素
  • 市場阻礙因素
  • 市場機會
  • 主要課題

第7章 市場區隔

  • 各類型
    • 輸出神經補綴
    • 輸入神經補綴
  • 技巧
    • 脊髓電刺激法
    • 腦深部刺激法
    • 迷走神經刺激法
    • 薦椎神經刺激法
    • 經顱磁刺激法
  • 各用途
    • 運動神經原障礙
    • 生理學的疾病
    • 認知障礙
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他地區

第8章 競爭情形

  • M&A分析
  • 協定,聯盟,夥伴關係
  • 新產品的銷售

第9章 主要企業

  • Abbott
  • Boston Scientific
  • Cochlear
  • Livanova
  • Med-El
  • Medtronic
  • NDI Medical
  • Neuropace
  • Nevro
  • Retina Implant
  • Second Sight
  • Sonova

第10章 市場未來展望

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 60474

People with hearing loss benefit from early identification; use of hearing aids, cochlear implants, and other devices. According to the World Health Organization estimates, around 466 million people worldwide have disabling hearing loss and by 2050 more than 900 million people are expected to suffer from the same. The cochlear implant is the oldest form of neuroprosthetic, which was approved for use by the US Food and Drug Administration (FDA), in 1984. This device proves to be beneficial for people, with deafness, or severely hard-of-hearing. This device can also be used by patients, who have experienced intense hearing loss, caused by disease or injury, allowing them to hear sounds in their environment. Hence, with the increasing incidences of hearing loss, scientists are investing more in novel neuroprosthetics, which will drive the market over the forecast period.

Key Market Trends

Input Neural Prosthetics Segment is Expected to Show Better Growth in the Forecast Years

Based on equipment, it is segmented into input neural prosthetics and output neural prosthetics. The Input neural prosthetics is expected to show better growth. It mainly includes a cochlear Implant and bionic eye/retinal Implant. These are electronic devices that can help to provide a sense of sound to a person, who is profoundly deaf or severely hard-of-hearing. The implant consists of an external portion that sits behind the ear and a second portion that is surgically placed under the skin. In the United States, roughly 58,000 devices have been implanted in adults and 38,000 in children, according to the US Food and Drug Administration. The market for these prosthetics is expected to show better growth, due to the higher number of children born with hearing defects, and the increasing awareness, along with growing research, in the field of neuroprosthetics.

North America Estimated to Hold the Largest Share in the Neuroprosthetics Market

The neuroprosthetics market estimated to hold the largest share in the North America region due to the increasing number of patients suffering from neurological disorders and nerve injury. Additionally, the number of cases, where children are born with hearing defects, is increasing. According to NIDCD (National Institute of Deafness and Other Communication Disorders), about 2 - 3 of every 1,000 children in the country, are born with a detectable level of hearing loss in one or both ears. According to NIH, nearly 188,000 individuals worldwide, are fitted with a cochlear implant. Hence, with the rising acceptance of neuroprosthetic technology, the market is expected to grow in the forecast period.

Competitive Landscape

The global players into the neuroprosthetics market are Abbott Laboratories, Boston Scientific Corporation, Cochlear Limited, Demant A/S, LivaNova PLC, MED-EL, Medtronic PLC, Oticon, Retina Implant AG and Sonova Holding AG.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Number of Patients Suffering from Neurological Disorders and Nerve Injury
    • 4.2.2 Growing Burden of Hearing Loss and Related Defects
  • 4.3 Market Restraints
    • 4.3.1 Availability of Alternative Treatment Options
    • 4.3.2 High Cost of Neuroprosthetics
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Type
    • 5.1.1 Output Neural Prosthetics
    • 5.1.2 Input Neural Prosthetics
  • 5.2 By Technique
    • 5.2.1 Spinal Cord Stimulation
    • 5.2.2 Deep Brain Stimulation
    • 5.2.3 Vagus Nerve Stimulation
    • 5.2.4 Other Techniques
  • 5.3 By Application
    • 5.3.1 Motor Neuron Disorders
    • 5.3.2 Physiological Disorders
    • 5.3.3 Cognitive Disorders
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Boston Scientific Corporation
    • 6.1.3 Cochlear Limited
    • 6.1.4 Demant A/S
    • 6.1.5 LivaNova PLC
    • 6.1.6 MED-EL
    • 6.1.7 Medtronic PLC
    • 6.1.8 Oticon
    • 6.1.9 Retina Implant AG
    • 6.1.10 Sonova Holding AG

7 MARKET OPPORTUNITIES AND FUTURE TRENDS